NVO
Novo-Nordisk A/S
stockNYSEADR
At CloseOct 23, 2026 3:59:56 PM EDT
39.03USD-1.014%(-0.40)9,188,277
Pre-marketOct 23, 2026 9:29:30 AM EDT
39.27USD-0.406%(-0.16)
After-hoursOct 23, 2026 4:57:30 PM EDT
38.90USD-0.333%(-0.13)
Loading…
Loading…
172.31B
Healthcare
Biotechnology
HQ
Bagsvaerd, Bagsvaerd, Denmark
57,089
Previous Close
$39.43
Beta
1.01
52-Week High
$64.16 2026-01-23
52-Week Low
$35.12 2026-03-30
SMA 50
$41.91
SMA 200
$44.69
Avg. Vol 10D
9.44M
Avg. Vol 30D
13.33M
Avg. Vol 90D
12.16M
Relative Vol
0.69
4.41B
3.17B
71.92%
31,622,458
1.00%
1.74
54%/46%
46.93%
22.79%
0.3700%
10,000,000
192
7,421
22,844
Nov 4, 2026 (10d)
Mar 31, 2025 · $1.099
Sep 20, 2023 · 2-for-1
Oct 23, 2026
Oct 22, 2026
What Is the Peptide Economy? Beyond the GLP-1 Boom · 
ETF Trends
Bristol Myers Squibb vs. Novo Nordisk: Stable Scale vs. GLP-1 Volatility · 
The Motley Fool
Oct 21, 2026
Where Will Novo Stock Be in 10 Years? · The Motley Fool
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.
NVO Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 38.83 | 2026-10-16 | +0.58% | -0.267 |
| 1M | 38.62 | 2026-09-24 | +1.13% | 0.312 |
| 3M | 48.77 | 2026-07-24 | -19.92% | -0.353 |
| 6M | 41.17 | 2026-04-24 | -5.14% | 0.021 |
| 1Y | 52.96 | 2025-10-24 | -26.26% | 1.013 |
| 2Y | 113.92 | 2024-10-24 | -65.72% | — |
| 5Y | 53.09 | 2021-10-25 | -26.43% | 0.671 |
NVO Stock Summary
Novo-Nordisk A/S (NYSE:NVO) stock price today is $39.06, and today's volume is 9,188,277. NVO is down 0.951% today. The 30 day average volume is 13.33M. NVO market cap is $172.31B with 4.41B shares outstanding.